Diabetic lipoproteins and adrenal aldosterone synthesis - A possible pathophysiological link?

Hormone and Metabolic Research

Volumn 44, Issue 3, 2012, Pages 239-244

  Saha, S ^a   Willenberg, H S ^b   Bornstein, S R ^a   Graessler, J ^a   Kopprasch, S ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

adrenocortical cells; extracellular signal regulated kinase; glycoxidation; oxidation; scavenger receptor

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ALDOSTERONE; ALDOSTERONE SYNTHASE; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN; HYPOCHLORITE SODIUM; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; VERY LOW DENSITY LIPOPROTEIN;

ADRENAL CORTEX CELL; ALDOSTERONE RELEASE; ARTICLE; CHOLESTEROL TRANSPORT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIABETES MELLITUS; ENZYME PHOSPHORYLATION; HORMONE SYNTHESIS; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; NORMAL HUMAN; OXIDATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN MODIFICATION; STEROIDOGENESIS; WESTERN BLOTTING;

ADRENAL CORTEX; ALDOSTERONE; ALDOSTERONE SYNTHASE; CELL LINE, TUMOR; DIABETES COMPLICATIONS; HUMANS; HYPERALDOSTERONISM; LIPOPROTEINS; OXIDATION-REDUCTION;

EID: 84858008813     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0031-1295459     Document Type: Article

References (22)

1. Matrozova J, Steichen O, Amar L, Zacharieva S, Jeunemaitre X, Plouin PF. Fasting plasma glucose and serum lipids in patients with primary aldosteronism: a controlled cross-sectional study. Hypertension 2009; 53: 605-610
2. Catena C, Lapenna R, Baroselli S, Nadalini E, Colussi G, Novello M, Favret G, Melis A, Cavarape A, Sechi LA. Insulin sensitivity in patients with primary aldosteronism: a follow-up study. J Clin Endocrinol Metab 2006; 91: 3457-3463 (Pubitemid 44402119)
3. Mosso LM, Carvajal CA, Maiz A, Ortiz EH, Castillo CR, Artigas RA, Fardella CE. A possible association between primary aldosteronism and a lower beta-cell function. J Hypertens 2007; 25: 2125-2130 (Pubitemid 47476311)
4. Fallo F, Veglio F, Bertello C, Sonino N, Della Mea P, Ermani M, Rabbia F, Federspil G, Mulatero P. Prevalence and characteristics of the metabolic syndrome in primary aldosteronism. J Clin Endocrinol Metab 2006; 91: 454-459 (Pubitemid 43236909)
5. Reincke M, Meisinger C, Holle R, Quinkler M, Hahner S, Beuschlein F, Bidlingmaier M, Seissler J, Endres S. Is primary aldosteronism associated with diabetes mellitus? Results of the German Conn's Registry. Horm Metab Res 2010; 42: 435-439
6. Wada T, Ohshima S, Fujisawa E, Koya D, Tsuneki H, Sasaoka T. Aldosterone inhibits insulin-induced glucose uptake by degradation of insulin receptor substrate (IRS) 1 and IRS2 via a reactive oxygen species-mediated pathway in 3T3-L1 adipocytes. Endocrinology 2009; 150: 1662-1669
7. Hitomi H, Kiyomoto H, Nishiyama A, Hara T, Moriwaki K, Kaifu K, Ihara G, Fujita Y, Ugawa T, Kohno M. Aldosterone suppresses insulin signaling via the downregulation of insulin receptor substrate-1 in vascular smooth muscle cells. Hypertension 2007; 50: 750-755 (Pubitemid 47442741)
8. Yamashita R, Kikuchi T, Mori Y, Aoki K, Kaburagi Y, Yasuda K, Sekihara H. Aldosterone stimulates gene expression of hepatic gluconeogenic enzymes through the glucocorticoid receptor in a manner independent of the protein kinase B cascade. Endocr J 2004; 51: 243-251 (Pubitemid 38657562)
9. Laverty G, Bjarnadottir S, Elbrond VS, Arnason SS. Aldosterone suppresses expression of an avian colonic sodium-glucose cotransporter. Am J Physiol Regul Integr Comp Physiol 2001; 281: R1041-R1050
10. Krug AW, Ehrhart-Bornstein M. Aldosterone and metabolic syndrome: is increased aldosterone in metabolic syndrome patients an additional risk factor? Hypertension 2008; 51: 1252-1258 (Pubitemid 351555932)
11. Sowers JR, Whaley-Connell A, Epstein M. Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension. Ann Intern Med 2009; 150: 776-783
12. Azhar S, Leers-Sucheta S, Reaven E. Cholesterol uptake in adrenal and gonadal tissues: the SR-BI and 'selective' pathway connection. Front Biosci 2003; 8: s998-s1029 (Pubitemid 38925366)
13. Maeba R, Shimasaki H, Ueta N. Conformational changes in oxidized LDL recognized by mouse peritoneal macrophages. Biochim Biophys Acta 1994; 1215: 79-86 (Pubitemid 24345058)
14. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, Ahn BW, Shaltiel S, Stadtman ER. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 1990; 186: 464-478 (Pubitemid 20279989)
15. Yagi K. A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med 1976; 15: 212-216
16. Quinkler M, Born-Frontsberg E, Fourkiotis VG. Comorbidities in primary aldosteronism. Horm Metab Res 2010; 42: 429-434
17. Giacchetti G, Sechi LA, Rilli S, Carey RM. The renin-angiotensin- aldosterone system, glucose metabolism and diabetes. Trends Endocrinol Metab 2005; 16: 120-126 (Pubitemid 40432462)
18. Howard BV. Lipoprotein metabolism in diabetes mellitus. J Lipid Res 1987; 28: 613-628 (Pubitemid 17085961)
19. Xing Y, Cohen A, Rothblat G, Sankaranarayanan S, Weibel G, Royer L, Francone OL, Rainey WE. Aldosterone production in human adrenocortical cells is stimulated by high-density lipoprotein 2 (HDL2) through increased expression of aldosterone synthase (CYP11B2). Endocrinology 2011; 152: 751-763
20. Nieland TJ, Chroni A, Fitzgerald ML, Maliga Z, Zannis VI, Kirchhausen T, Krieger M. Cross-inhibition of SR-BI- and ABCA1-mediated cholesterol transport by the small molecules BLT-4 and glyburide. J Lipid Res 2004; 45: 1256-1265 (Pubitemid 38802628)
21. Fardella CE, Mosso L, Gomez-Sanchez C, Cortes P, Soto J, Gomez L, Pinto M, Huete A, Oestreicher E, Foradori A, Montero J. Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology. J Clin Endocrinol Metab 2000; 85: 1863-1867 (Pubitemid 32269290)
22. Gomez-Sanchez CE, Rossi GP, Fallo F, Mannelli M. Progress in primary aldosteronism: present challenges and perspectives. Horm Metab Res 2010; 42: 374-381